Article

lock Open Access lock Peer-Reviewed

1

Views

CLINICAL RESEARCH PAPER

Cardiac tumours: clinical, echocardiographic and pathological features

Ricardo Pereira Silva; Aglaerton Pinheiro; Ieda Costa; José Eloy da Costa Filho; Carlos Roberto Martins Rodrigues Sobrinho; Pedro José Negreiros de Andrade; João Martins de Sousa Torres; Eduardo Régis Monte Jucá

DOI: 10.1590/S0102-76382003000100012

INTRODUCTION

Cardiac tumours are rare. In findings from autopsies, while a frequency of 1% for secondary tumours is observed, this incidence drops to 0.056% in respect to primary tumours [1].

Clinical diagnosis of cardiac tumours, both primary and secondary, almost always occurs in the final stages of the disease due to the lack of clinical symptoms. Many cardiac tumours can be cured with early diagnosis. Recent developments in echocardiograms (ECGs), specifically using the transoesophageal method, facilitate the non-invasive diagnosis of tumours. ECGs can define the anatomy of the tumour and aid its resection [2]. Diagnosis of cardiac tumours can be performed even before birth, using foetal ECGs [3,4].

Cardiac catheterism can also demonstrate the presence of a tumour. Coronary cineangiography can be useful in the evaluation of atrial myxomas by demonstrating the vascular `blush' in the tumour.

Benign tumours constitute the majority of cardiac tumours and among them, the most common is the myxoma [6]. A Chinese study demonstrated the presence of 50% of myxomas in all tumours discovered, with lipoma the second most common benign tumour evidenced. This study determined an incidence of 21% of malignant tumours, with angiosarcoma and rhabdomyosarcoma being the most common [7]. In 95% of the cases the myxomas appear in left chambers, although a case of a myxoma obstructing the outlet of the right ventricle has been reported [8]. Contrary to benign tumours, malignant tumours, in particular the angiosarcomas present a short and fatal evolution [9].

In relation to complications caused by cardiac tumours, ischemic stroke [10], pulmonary emboli [11] and myocardial infarction [12] have been reported.

The aims of this work are to characterise patients with tumours, both clinically and using ECG, to evaluate the morbid-mortality of this disease, to evaluate the surgical procedure and to investigate reoccurrence of tumours.

METHOD

In the initial phase of the research, a retrospective methodological delimitation was performed, by the identification of cardiac tumour cases and the collection of data. An investigation of patients' records from the Walter Cantidio Teaching Hospital of the Federal University of Ceara and the Messejana Hospital of the Health Department of the State of Ceara, Brazil during the period from 1981 to 2001 was made. A total of 19 cases of cardiac tumours were found, of which 6 patients (31.58%) were male and 13 (68.42%) were female with ages ranging from 50 days to 70 years (mean of 40.52 years and a median of 46 years).

A cardiac tumour was considered present if an intracardiac mass with the specific characteristics of this disease was seen either during two echocardiographic examinations or on one ECG and by cardiac catheterism. Confirmation was by surgery or necropsy. The patients were submitted to clinical, echocardiograph and electrocardiograph re-evaluations during the period from March until July 2002 by means of an investigation of the patients' records, subsequent consultations and return visits to the physician.

The ECG employed at the start of the 1960s utilised only the M mode with the 2-dimensional mode being used from 1984 onwards. As the transoesophageal ECG was not available in our department, this technique was not used for the initial diagnosis of the tumours, but it was later used to confirm a reoccurrence of one tumour seven years after resection.

The research protocol was approved by the research ethics committee of the Walter Cantidio Teaching Hospital.

RESULTS

The time of evolution until diagnosis varied from 48 days until 10 years, with a mean of 39 months and a median of 10 months. Systemic, cardiac and embolic symptoms were evidenced as demonstrated in Table 1.

Table 1. Principal clinical manifestations presented by patients with cardiac tumours


The most prevalent signs were paleness and jugular turgidity as is shown on Table 2. The cardiac auscultation was abnormal in 73.68% of the patients of which the most common alteration was mitral systolic murmur (36.84%). Also alterations in the noise and the rhythm were evidenced as demonstrated in Table 3.

Table 2. Most prevalent signs in patients with cardiac tumours


Table 3. Cardiac auscultation in patients with cardiac tumours


The pre-operative ECG was analysed in all patients and revealed an increase in the heart chambers in 72.2% of the individuals, with an overload of the right ventricle being the most common finding (33.3%). Atrial fibrillation was observed in 11% of the patients and conduction disorders in 27% (Table 4). The ECG was performed in 18 patients, in two only using the M mode, which was the only available technique at the time of the examination. In one of them, the presence of the tumour was not evidenced but was later observed by cardiac catheterism. The most frequent site of the tumours was in the left ventricle (66.6% of the cases). Other findings were evidenced such as hypertrophy of the chambers and pulmonary hypertension (16.67%) as illustrated in Table 5.

Table 4. Electrocardiogram in patients with cardiac tumours


Table 5. Echocardiographic characteristics of patients with cardiac tumours.


Ten of the patients (52.6%) were submitted to catheterism with one mortality during the examination. In one of the patients, the tumour was not detected by catheterism, but two future ECGs demonstrated the tumour and the patient was submitted to surgery with the resection of a tumour from the left atrium. Pulmonary hypertension was present in half of the study group (Table 6). Another patient presented with acute pulmonary oedema and died before being considered for operation.

Table 6. Cardiac catheterism in patients with cardiac tumours


Among the 17 surviving patients, surgery was performed in 14 and refused by three. Tumours were resected from the left atrium in 11 (78.57%) of the cases, and from the right atrium in 3 (21.42%). In one patient with a tumour in the right atrium, infiltration was evidenced in the vena cava during surgery. Some associated procedures were performed, such as mitral plasty (14.28%), tricuspid plasty (7.14%) and valve replacement using a bioprosthesis (7.14%).

Histopathologic diagnoses of lesions were carried out in nine patients and found compatible with benign tumours in seven cases (77.78%), all of which were myxoma. Two malignant tumours were also diagnosed, one myxosarcoma (11.11%) and the other thymoma (11.11%).

The observed evolution in the 14 patients submitted to surgeries included two patient deaths (14.29%), one due to cardiac shock in the immediate post-operative period and the other during surgery; one patient suffered reoccurrence of the tumour. Other events evidenced during the long-term post-operative period were angina in one, left branch occlusion in one, congestive heart failure in two, arterial hypertension in two and arrhythmia in one patient. Of the three patients who refused surgery, one suffered from persistent anginose pain and the other two did not return for check ups.

COMMENTS

The majority of patients with cardiac tumours in our study were female in agreement with published reports [13,14]. The age range was very variable, from 50 days to 70 years which is again similar to other studies [13] but the mean age found in our investigation of 40 years was a little lower than that found in French studies [14].

Congestion and abdominal pain were the most common symptoms seen in our studies similar to what was reported by Mirales et al. [14]. These authors observed neurologic symptoms in 17% of their patients whereas we evidenced neurological disturbances in only 5% of ours.

The most common location of the cardiac tumours in our investigation, observed using ECG and cardiac catheterism, was the left atrium in 66% of the cases. Blondeau [13] identified the left atrium as the affected chamber in 83% of the cases of myxoma. Among the patients who underwent operations, all had the tumour resected from the atria, predominantly from the left atrium (79% of the cases). Using ECG it is possible to analyse the site of the tumour, fixation type, growth type, its limits, its echocardiographic texture, echogenic status, shape, nucleus of growth, dimensions, dynamic aspects and the hemodynamic repercussions of the tumour mass, which enables characterisation with the minimum utilisation of invasive methods [15].

Pulmonary hypertension, detected in 50% of the patients submitted to catheterism, was only found in 16% of the patients in whom ECGs were performed. This can be explained by the fact that some ECG examinations were performed without the Doppler technique, which was unavailable at that time.

The most common histopathologic type of tumour discovered in our series, myxoma, was observed in 78% of the patients, corresponding to 100% of the benign tumours found. This frequency is similar to that reported by Blondeau [13], but Meng et al. [7] detected only 50% of myxoma in the total tumours found. We must emphasise the finding of a thymoma, which is a rare malignant tumour in the heart.

Surgical mortality seen in our series (14%) was high when compared to a French series that presented a mortality rate of less than 1% [13]. In a Brazilian study of 15 cases operated for myxoma, a survival rate of 93% in the first 6 post-operative months was reported [16].

Reoccurrence of tumours was evidenced in only one patient where the histologic type was myxoma. Basically, there are two mechanisms, which explain relapse of cardiac tumours: the first is inadequate resection of the tumour and the second is the presence of a multifocal disease. In the latter case the tumour appears in a different heart chamber each time, has a familiar tendency and pigmented skin lesions emerge. This is denominated as the Carney Syndrome [17,18]. In our case of recurrence, a tumour was found in the same heart chamber on both occasions, in this case the left atrium, which suggests that there was inadequate resection of its first appearance.

CONCLUSIONS

Cardiac tumours were found more frequently in the left atrium. The benign tumours were more frequent than malignant. The commonest histopathologic type was myxoma.

BIBLIOGRAPHIC REFERENCES

1. Lam KY, Dickens P, Chan AC. Tumors of the heart: a 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993; 117: 1027-31.
[ Medline ]

2. Goldman JH, Foster E. Transesophageal echocardiographic (TEE) evaluation of intracardiac and pericardial masses. Cardiol Clin 2000; 18: 849-60.
[ Medline ]

3. Lethor JP, de Moor M. Multiple cardiac tumors in the fetus. Circulation 2001; 103:E55

4. Elderkin RA, Radford DJ. Primary cardiac tumours in a pediatric population. J Paediatr Child Health 2002; 38: 173-7.

5. Sawaya JI, Dakik HA. Angiographic visualization of an atrial myxoma. N Engl J Med 2000; 342: 294-5.
[ Medline ]

6. Cruz JF, Dias LB, Rodrigues Neto JO, de Oliveira SA. Mixoma gigante de átrio esquerdo. Arq Bras Cardiol 1998; 71: 717-8.
[ Medline ] [ Lilacs ] [ SciELO ]

7. Meng Q, Lai H, Lima J, Tong W, Qian Y, Lai S. Echocardiographic and pathologic characteristics of primary cardiac tumors: a study of 149 cases. Int J Cardiol 2002; 84: 69-75.
[ Medline ]

8. Gopal AS, Arora NS, Messineo FC. Right ventricular myxoma. N Engl J Med 2000; 342: 295.

9. Frota Filho JD, Lucchese FA, Leães P, Valente LA, Vieira MS, Blacher C. Angiossarcoma cardíaco primário. Um dilema terapêutico. Arq Bras Cardiol 2002; 78: 586-91.
[ Lilacs ]

10. Takakura IT, de Godoy MF, Soares MJ, Moscardini AC, Braile DM. Mixoma atrial esquerdo com acidente vascular cerebral isquêmico em criança. Arq Bras Cardiol 1998; 71: 135-7.
[ Medline ] [ Lilacs ] [ SciELO ]

11. Manfroi W, Vieira SR, Saadi EK, Saadi J, Alboim C. Múltipla recorrência de mixomas cardíacos com embolia pulmonar aguda. Arq Bras Cardiol 2001;77: 161-6.
[ Medline ] [ Lilacs ]

12. Meira EB, Ho CL, Santos Filho MM, Pimenta J. Mixoma de átrio esquerdo provocando infarto agudo do miocárdio. Arq Bras Cardiol 1996; 67: 347-9.
[ Medline ] [ Lilacs ]

13. Blondeau P. Primary cardiac tumors: French studies of 533 cases. Thorac Cardiovasc Surg 1990; 38 (Suppl 2): 192-5.

14. Miralles A, Bracamonte L, Soncul H, Diaz del Castillo R, Akhtar R, Bors V et al. Cardiac tumors: clinical experience and surgical results in 74 patients. Ann Thorac Surg 1991; 52:886-95.
[ Medline ]

15. Barbato AJG. Contribuição da ecodopplercardiografia na avaliação dos envolvimentos tumorais do coração e do pericárdio: correlação com aspectos clínicos e anatomopatológicos [Tese de livre-docência]. São Paulo: Universidade de São Paulo, 1990. 160p.

16. Terrazas MB, Jazbik AP, Buffolo E, Jazbik W, Ramalho G. Tratamento cirúrgico dos mixomas cardíacos: relato de 15 casos operados e revisão da literatura. Rev Col Bras Cir 1981; 8: 208-13.
[ Lilacs ]

17. Shinfeld A, Katsumata T, Westaby S. Recurrent cardiac myxoma: seeding or multifocal disease? Ann Thorac Surg 1998; 66: 285-8.
[ Medline ]

18. Amir O, Merdler A, Shiran A. Bilateral atrial myxomas associated with hyperpigmented skin lesions. N Engl J Med 2001; 344: 938-9.
[ Medline ]

CCBY All scientific articles published at bjcvs.org are licensed under a Creative Commons license

Indexes

All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY